| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |